This article contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (January 2024) (Learn how and when to remove this message) |
Ravgen Inc. is a privately owned biotech company founded in 2000 by Chairman and C.E.O. Dr. Ravinder Dhallan. Ravgen Inc. performs research in the prenatal diagnostic field and has developed non-invasive prenatal diagnosis testing for Down Syndrome.
Publications and research
Ravgen has published peer-reviewed articles on genetic research in publications such as the Journal of the American Medical Association in 2004, The Lancet in 2007, and the New England Journal of Medicine in 2012. In addition, Ravgen has received some acclaim from its research on non-invasive prenatal DNA testing.
References
- Hanoon, Alaa; Rahan, Nur Nadiah Mohd; Hamid, Nur Nadiah Abd; Ismail, Ahmad Izani Md (2018). Solving the nonlinear Camassa Holm equation using quartic trigonometric B-spline collocation method. Mathematical Sciences as the Core of Intellectual Excellence (Sksm25). AIP Conference Proceedings. Vol. 1974. Author(s). p. 020034. Bibcode:2018AIPC.1974b0034H. doi:10.1063/1.5041565.
- Humphries, Courtney (February 2, 2007). "A Simpler Test for Detecting Down's Syndrome | MIT Technology Review". Technologyreview.com. Retrieved August 17, 2013.
- Dhallan, Ravinder; Au, W. C.; Mattagajasingh, S.; Emche, S.; Bayliss, P.; Damewood, M.; Cronin, M.; Chou, V.; Mohr, M. (2004). "Methods to Increase the Percentage of Free Fetal DNA Recovered from the Maternal Circulation". JAMA. 291 (9). The Journal of the American Medical Association: 1114–1119. doi:10.1001/jama.291.9.1114. PMID 14996781. Archived from the original on May 11, 2012.
- Dhallan, Ravinder; Guo, Xin; Emche, Sarah; Damewood, Marian; Bayliss, Philip; Cronin, Michael; Barry, Julie; Betz, Jordan; Franz, Kara; Gold, Katie; Vallecillo, Brett; Varney, John (2007). "A noninvasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study". The Lancet. 369 (9560): 474–481. doi:10.1016/S0140-6736(07)60115-9. PMID 17292767. S2CID 43348652.
- Guo, Xin (2012). "A Noninasive Test to Determine Paternity in Pregnancy". The New England Journal of Medicine. 366 (18): 1743–1745. doi:10.1056/NEJMc1113044. PMID 22551147.
- "Health | Hope for safe prenatal gene test". BBC News. February 2, 2007. Archived from the original on April 19, 2012. Retrieved August 17, 2013.
External links
- Ravgen's official website
- JAMA (The Journal of the American Medical Association) "Methods to Increase the Percentage of Free Fetal DNA Recovered from the Maternal Circulation"
- The Lancet "A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study"